Get the Stockscreener App
59.96
1.61%
0.95
After Hours:
59.96
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $59.96, with a volume of 7.29M.
It is up +1.61% in the last 24 hours and up +6.14% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
See More
Previous Close:
$59.01
Open:
$58.98
24h Volume:
7.29M
Relative Volume:
0.68
Market Cap:
$74.26B
Revenue:
$368.91B
Net Income/Loss:
$5.02B
P/E Ratio:
9.0437
EPS:
6.63
Net Cash Flow:
$1.69B
1W Performance:
+5.51%
1M Performance:
+6.14%
6M Performance:
+7.96%
1Y Performance:
-12.77%
1-Day Range:
$58.89
$60.10
1-Week Range:
$56.40
$60.29
52-Week Range:
$52.71
$83.25
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
59.96 | 74.26B | 368.91B | 5.02B | 1.69B | 6.63 |
|
UNH
Unitedhealth Group Inc
|
608.38 | 558.42B | 389.07B | 14.32B | 13.10B | 23.04 |
|
CI
Cigna Group
|
336.50 | 94.39B | 229.75B | 3.04B | 5.18B | 17.73 |
|
ELV
Elevance Health Inc
|
402.75 | 94.02B | 174.02B | 6.42B | 871.00M | 25.47 |
|
HUM
Humana Inc
|
296.68 | 35.96B | 115.01B | 1.36B | -4.34B | 24.12 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Payer Roundup—Trump AG pick has ACA history; GLP-1s costing BCBSMA - Fierce healthcare
Pennsylvania pharmacies seek to centralize GoodRx antitrust claims in Rhode Island - Reuters.com
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - MSN
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS cuts jobs at troubled Aetna - The Business Journals
CVS broadens its ‘mass layoff’ with more CT positions cut. What to know. - Hartford Courant
CVS Health price target lowered to $64 from $72 at Piper Sandler - Yahoo Finance
CVS Health's SWOT analysis: stock outlook amid Medicare shifts, leadership change - Investing.com
CVS Health stock holds Overweight; Piper Sandler focuses on strong Aetna MA franchise - Investing.com
CVS Health stock target increased, buy rating on MA turnaround hopes - Investing.com
Piper Sandler Lowers CVS Health (NYSE:CVS) Price Target to $64.00 - MarketBeat
CVS Health price target raised to $80 from $73 at TD Cowen - TipRanks
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too? - The Motley Fool
CVS names Dr. Sreekanth Chaguturu president of health care delivery - Providence Business News
CVS Health Co. (NYSE:CVS) Shares Sold by Borer Denton & Associates Inc. - MarketBeat
Sompo Asset Management Co. Ltd. Boosts Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Cerity Partners LLC Trims Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Meridian Wealth Management LLC Buys New Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 361,764 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Segall Bryant & Hamill LLC Takes $1.85 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Thrivent Financial for Lutherans Has $5.73 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Stock Price | CVS Stock Quote, News, and History - Markets Insider
CVS (CVS Health) 5-Day RSI : 68.20 (As of Nov. 23, 2024) - GuruFocus.com
Intech Investment Management LLC Has $6.07 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health bulks its board up to 16 members, adds hedge fund CEO - MSN
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Raymond James Trust N.A. Reduces Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Banco Santander S.A. - MarketBeat
Charles Schwab Investment Management Inc. Has $767.68 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Integrated Investment Consultants LLC Takes Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Stake Lowered by Mizuho Securities USA LLC - MarketBeat
Thompson Siegel & Walmsley LLC Has $6.04 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Pacer Advisors Inc. Buys 15,889 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Moran Wealth Management LLC Lowers Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
News | Trump Names Bondi, Former FL AG Who Sued CVS on Opioids, to Serve as U.S. Attorney General - GoLocalProv
CVS Health Corp. stock rises Thursday, still underperforms market - MarketWatch
CVS Health (LIM:CVS) Total Inventories : $17,649 Mil (As of Sep. 2024) - GuruFocus.com
Landscape Capital Management L.L.C. Has $4.75 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Stock Position Decreased by Primecap Management Co. CA - MarketBeat
99,900 Shares in CVS Health Co. (NYSE:CVS) Purchased by Payden & Rygel - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Purchased by Advisors Asset Management Inc. - MarketBeat
PNC Financial Services Group Inc. Has $46.82 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
61,838 Shares in CVS Health Co. (NYSE:CVS) Acquired by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat
CVS Can't Dodge Proposed Action Over 'Non-Drowsy' Claims - Law360
CVS Hit With California Class Action After Minute Clinic Layoffs - Bloomberg Law
CVS Illegally Laid Off Clinic Workers, Nurse Practitioner Says - Law360
Oak Street Health co-founder departs CVS - Healthcare Dive
New York targets PBMs with new transparency, competition rules - Modern Healthcare
Is CVS Health Stock an Underrated Buy? - Yahoo! Voices
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant - MSN
Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):